[go: up one dir, main page]

KR20020051803A - Bacillus Amyloliquefaciens CHO104 with Antagonic Property and Antimicrobial Compound Produced by This Strain - Google Patents

Bacillus Amyloliquefaciens CHO104 with Antagonic Property and Antimicrobial Compound Produced by This Strain Download PDF

Info

Publication number
KR20020051803A
KR20020051803A KR1020000081428A KR20000081428A KR20020051803A KR 20020051803 A KR20020051803 A KR 20020051803A KR 1020000081428 A KR1020000081428 A KR 1020000081428A KR 20000081428 A KR20000081428 A KR 20000081428A KR 20020051803 A KR20020051803 A KR 20020051803A
Authority
KR
South Korea
Prior art keywords
cho104
disease
culture
fractions
bacillus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1020000081428A
Other languages
Korean (ko)
Other versions
KR100423121B1 (en
Inventor
박근형
조정일
조정용
이승제
Original Assignee
조정일
박근형
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 조정일, 박근형 filed Critical 조정일
Priority to KR10-2000-0081428A priority Critical patent/KR100423121B1/en
Publication of KR20020051803A publication Critical patent/KR20020051803A/en
Application granted granted Critical
Publication of KR100423121B1 publication Critical patent/KR100423121B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07Bacillus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

본 발명은 곰팡이 및 세균에 길항성을 갖는 미생물을 토양에서 분리하여 바실러스 아밀로리퀴파시엔스 CHO104(Bacillus amyloliquefaciensCHO104)로 동정된 미생물의 배양액으로부터 분리한 항균활성물질 및 그의 분리방법 그리고 길항성을 갖는 미생물제제에 관한 것이다. 보다 상세하게는 길항성을 갖는 바실러스 아밀로리퀴파시엔스 CHO104(수탁번호: KCTC 18060P)의 배양액으로부터 아밀로리퀴톤(amyloliquetone)으로 명명한 항균활성물질을 발견하였다.The present invention has an antimicrobial active material isolated from a culture medium of microorganisms identified as Bacillus amyloliquefaciens CHO104 by separating microorganisms having antagonism against mold and bacteria from soil and having an antagonism It relates to a microbial agent. More specifically, an antimicrobial activity named amyloliquetone was discovered from a culture of Bacillus amyloliquifaciens CHO104 (Accession Number: KCTC 18060P) having antagonism.

바실러스 아밀로리퀴파시엔스 CHO104의 배양액을 원심분리하여 균체를 제거한 배양여액을 얻고, 용매분획, 실리카겔 흡착 컬럼 크로마토그래피, 세파덱스 LH-20 컬럼 크로마토그래피, 옥타데실실란 컬럼 크로마토그래피, 역상-HPLC 등의 단계를 거쳐 최종적으로 항균활성물질을 단리하였으며, 이 항균활성물질의 구조는 MS, NMR분석에 의해 결정되었다.Centrifuge the culture medium of Bacillus amyloliquifaciens CHO104 to obtain the culture filtrate from which the cells were removed. Finally, the antimicrobial active material was isolated through the steps of, and the structure of the antimicrobial active material was determined by MS and NMR analysis.

본 발명의 아밀로리퀴톤 및 바실러스 아밀로피퀴파시엔스 CHO104 미생물제제는 항균효과가 있는 천연 항균제로서 의약품, 농약, 식품 등에 이용 등 광범위한 용도를 제공하게 될 것이다.Amyloquiquitone and Bacillus amylopiquifaciens CHO104 microbial agent of the present invention will provide a wide range of applications, such as natural antibacterial agent with antimicrobial effect, such as pharmaceuticals, pesticides, foods and the like.

Description

길항미생물 바실러스 아밀로리퀴파시엔스 조104 및 이 균주가 생산하는 항균물질{Bacillus Amyloliquefaciens CHO104 with Antagonic Property and Antimicrobial Compound Produced by This Strain}Antagonist microorganism Bacillus amyloliquefaciens crude 104 and antibacterial substance produced by this strain {Bacillus Amyloliquefaciens CHO104 with Antagonic Property and Antimicrobial Compound Produced by This Strain}

본 발명은 토양유래의 길항미생물로, 바실러스 아밀로리퀴파시엔스 CHO104로 분리·동정된 미생물의 배양액으로부터 분리한 항균활성물질인 아밀로리퀴톤(amyloliquetone)과 그의 분리방법에 관한 것이다. 보다 상세하게는 곰팡이, 세균 등의 미생물 생육을 억제시키는 길항효과가 뛰어난 균주로 선발되고 동정된 바실러스 아밀로리퀴파시엔스 CHO104로 동정된 이 미생물(수탁번호: KCTC 18060P)은 길항효과가 뛰어나며 또한 이 미생물의 배양액으로부터 아밀로리퀴톤으로 명명한 항균활성물질을 분리하였다.The present invention relates to an antimicrobial active substance amyloliquetone (amyloliquetone) isolated from a culture medium of microorganisms isolated and identified with Bacillus amyloquifaciens CHO104 as soil-derived antagonist microorganisms, and a method for separating the same. More specifically, this microorganism (accession number: KCTC 18060P) selected and identified as Bacillus amyloliquifaciens CHO104, which was selected and identified as an excellent antagonistic strain that inhibits the growth of microorganisms such as fungi and bacteria, has an excellent antagonistic effect. The antimicrobial active substance named amyloquiquitone was isolated from the culture medium of microorganisms.

토양에서 분리한 바실러스 아밀로리퀴파시엔스 CHO104는 곰팡이 및 세균의 생육을 강력히 억제하는 길항작용을 보여, 이 균이 미생물의 생육을 저해하는 항미생물 활성물질을 생산하고 있는 사실을 실험적으로 확인하였으나, 항미생물 활성 원인물질을 알 수 없어, 본 발명자들은 이 균주를 배양하여 얻어진 배양액에 함유된 길항원인 활성물질을 분리하고, 구조결정에 성공하였다. 본 발명의 바실러스 아밀로리퀴파시엔스가 생산하는 항균활성물질인 아밀로리퀴톤에 관한 보고는 없다.Bacillus amyloliquifaciens CHO104 isolated from soil showed an antagonistic effect of inhibiting the growth of fungi and bacteria, and experimentally confirmed that the bacteria produce antimicrobial actives that inhibit the growth of microorganisms. Since the antimicrobial activity causative agent is unknown, the present inventors have isolated the active substance which is an antagonist contained in the culture obtained by culturing this strain, and succeeded in the structure determination. There is no report on amyloliquitone, which is an antimicrobial active substance produced by Bacillus amyloliquifaciens of the present invention.

본 발명은 곰팡이, 세균 등의 생육을 강력히 억제시키는 길항성 미생물을 토양에서 분리·선발하고, 이 균주를 바실러스 아밀로리퀴파시엔스 CHO104로 동정하였으며, 이 균주의 배양액으로부터 길항원인 활성물질로 아밀로리퀴톤으로 명명한 천연 항균활성물질을 분리하고 구조결정함으로써 이 균주가 갖는 길항원인물질인 항균활성물질을 발견하였으며, 또한 분리방법을 발견하였다.The present invention isolates and selects antagonistic microorganisms that strongly inhibit the growth of fungi, bacteria, etc. in the soil, and identifies this strain as Bacillus amyloliquifaciens CHO104. By separating and structuring the natural antimicrobial active substance named quiton, the antimicrobial active substance, which is an antagonist of this strain, was found, and also the separation method was found.

본 발명의 아밀로리퀴톤 및 바실러스 아밀로리퀴파시엔스 CHO104 미생물제제는 항균효과가 있는 항균제로서 의약품, 농약, 식품 등에 광범위한 용도를 제공하게 될 것이다.Amyloquiquitone and Bacillus amyloliquifaciens CHO104 microbial agent of the present invention will provide a wide range of applications, such as pharmaceuticals, pesticides, foods, etc. as an antimicrobial agent having an antimicrobial effect.

본 발명은 병원성 곰팡이와 세균의 생육 억제 효과가 뛰어난 길항성 세균 CHO104를 토양에서 분리하고, 동정한 결과 바실러스 아밀로리퀴파시엔스(Bacillus amyloliquefaciens)로 동정되어 2000년 11월 18일자로 한국과학기술원 생명공학연구소에 수탁(미생물의 명칭:Bacillus amyloliquefaciensCHO104, 수탁번호: KCTC 18060P)하였다.The present invention is isolated from the soil antagonistic bacteria CHO104 excellent in inhibiting the growth of pathogenic fungi and bacteria in the soil, and identified as Bacillus amyloliquefaciens (Nov. 18, 2000 ) Commissioned to the Institute of Engineering (Bacterial name: Bacillus amyloliquefaciens CHO104, Accession No .: KCTC 18060P).

이 미생물을 배양하여 얻어진 배양액을 원심분리하여 균체를 제거한 배양여액을 취한 후, 용매분획, 실리카겔 흡착 컬럼 크로마토그래피, 세파덱스 LH-20 컬럼 크로마토그래피, 옥타데실실란 컬럼 크로마토그래피, HPLC 등의 단계를 거쳐 최종적으로 항균활성물질을 단리하였으며, 이 항균활성본체의 구조는 MS, NMR 분석에의해 결정되었다.The culture solution obtained by culturing the microorganism was centrifuged to obtain the culture filtrate from which the cells were removed. Then, the following steps were performed: solvent fractionation, silica gel adsorption column chromatography, Sephadex LH-20 column chromatography, octadecyl column chromatography, and HPLC. Finally, the antimicrobial active material was isolated and the structure of the antimicrobial active body was determined by MS and NMR analysis.

이하, 하기 실시예에 의거하여 본 발명을 구체적으로 설명한다.Hereinafter, the present invention will be specifically described based on the following examples.

(실시예 1) 자연계로부터 길항미생물의 분리Example 1 Isolation of Antagonistic Microorganisms from Nature

식물의 병원성미생물에 길항성을 갖는 미생물을 선발하고자, 표1에서 제시한 식물병원균에 감염된 식물로부터 병원균을 분리하였다.In order to select microorganisms having antagonism to the pathogenic microorganisms of plants, pathogens were isolated from plants infected with the phytopathogens shown in Table 1.

각종 병원균에 대한 길항미생물 선발은 전국에서 수집된 각종의 토양시료를 tris-HCl 완충용액(pH 7.5) 100 mL에 잘 혼합한 후 영양배지(Nutrient Broth)에 접종하여 25℃에서 30분간 배양시켰다. 배양액 일부를 취하여 생리식염수 (0.85% NaCl)에 단계적으로 희석하여 적정 농도로 영양한천배지(Nutrient Agar)상에 도포한 후 25℃에서 3일간 배양한 후 나타난 균총을 분리하였다. 병원 식물 병원균에 대한 길항성 실험을 위하여, 감자 포도당 한천배지(Potato Dextrose Agar)중앙에 식물 병원성 곰팡이들을 각각 접종하여 25℃에서 1일 배양한 후 주위 네 지점에 분리된 걸항성세균을 접종하여 7일간 대치 배양 후 생육저해(Inhibition Zone)를 형성한 균주를 길항성세균으로 선발하였다. 이때 길항력의 정도는 대치배양한 경우와 곰팡이만 배양한 경우의 곰팡이 생육환의 지름을 측정하여 아래의 식으로 결정하였다. 그 결과, 길항성이 뛰어난 길항세균 CHO104를 선발하였으며 이 균주의 길항력을 표 2에 나타내었다.Antagonist microbial selection for various pathogens was mixed well with 100 mL of tris-HCl buffer solution (pH 7.5) collected from all over the country and incubated in nutrient broth (Nutrient Broth) and incubated for 30 minutes at 25 ℃. A portion of the culture solution was taken and diluted in physiological saline (0.85% NaCl) stepwise and applied to a proper concentration on nutrient agar (Nutrient Agar) and incubated for 3 days at 25 ℃ to isolate the bacterial flora. In order to antagonize the pathogenic pathogens of plants, inoculate each plant pathogenic fungus in the center of potato dextrose agar, incubate at 25 ° C for 1 day, and then inoculate the isolated antibacterial bacteria at four sites. Strains that formed inhibition of growth (Inhibition Zone) after daily replacement culture were selected as antagonistic bacteria. At this time, the degree of antagonism was determined by the following formula by measuring the diameter of mold growth ring in case of replacement culture and in case of only mold culture. As a result, antagonistic bacteria CHO104 excellent in antagonism were selected and their antagonistic power is shown in Table 2.

길항력 (Zone of Inhibition) = (NT - T)/NT ×100Zone of Inhibition = (NT-T) / NT × 100

NT : 무처리구의 균총 지름[colony diameter of no treatment(mm)]NT: colony diameter of no treatment (mm)

TN : 처리구의 균총 지름[colony diameter of treatment(mm)]TN: colony diameter of treatment (mm)

(실시예 2) 선발된 길항성세균 CHO104의 미생물 생육억제효과Example 2 Inhibition of Microbial Growth of Selected Antagonist Bacteria CHO104

각종의 식물 병원성 곰팡이를 감자 포도당 한천 사면배지 상에 접종하여 7일간 배양한 후 멸균된 Tween 80용액(0.1%, v/v) 1 mL와 멸균 증류수 5 mL을 가하여 포자를 씻어내고 여과지에 여과시켰다. 얻어진 포자를 멸균 증류수로 3회 씻어준 후 mL당 107~108개의 포자가 포함되도록, Tween 80용액과 증류수에 다시 현탁시켰다. 길항성 세균은 SDBP 배지(간장 3%, 포도당 5%, 비프 익스트렉트 0.1%, 프로테오스 펩톤 0.1%) 50 mL에 길항세균 1 mL을 접종하여 30℃에서 3일간 배양하여 사용하였다.Various plant pathogenic fungi were inoculated on potato glucose agar medium, incubated for 7 days, and 1 mL of sterile Tween 80 solution (0.1%, v / v) and 5 mL of sterile distilled water were added to wash the spores and filtered through a filter paper. . After three times washing the resulting semi spores in sterile distilled water so that it contains 10 7 to 10 8 spores per mL, it was then suspended in Tween 80 and distilled water solution. Antagonist bacteria were inoculated with 1 mL of antagonistic bacteria in 50 mL of SDBP medium (3% soy sauce, 5% glucose, 0.1% beef extract, 0.1% proteose peptone) and incubated at 30 ° C. for 3 days.

1) 길항균 배양액 살포가 유해곰팡이 억제효과1) Inhibition of harmful fungi by spraying antagonistic broth

식물 병원성 곰팡이를 감자 포도당 한천배지에 각각 접종하여 1일간 배양한곰팡이를 감자 포도당 한천배지에 각각 접종하여 1일간 배양한 후 길항균 CHO104가 포함된 배양액 1 mL씩을 생육중인 곰팡이 표면에 부은 후 25℃에서 7일간 배양하면서 생육도를 대조구와 비교하여 길항력을 조사하였다. 실험결과, 표 3에 제시한 바와 같이 모든 병원성 곰팡이에서 95%이상의 억제율을 보였으며, 특히 겹무늬썩음병(부패병), 탄저병, 점무늬낙엽병(반점낙엽병), 부란병, 줄기마름병(동고병), 푸른곰팡이병, 시들음병, 잘록병(입고병), 잿빛곰팡이병, 뿌리썩음병, 자주날개무늬병(자문우병), 흰날개무늬병(흰문우병) 원인 곰팡이의 경우는 완전히 억제되었다.Inoculate each plant pathogenic fungus with potato glucose agar medium and incubate for 1 day. Inoculate each of the fungus with potato glucose agar medium and incubate for 1 day. Then, pour 1 mL of the culture solution containing the antagonist CHO104 onto the surface of the growing fungus. Incubation for 7 days was compared with the control group to check the antagonism. As a result of the experiment, as shown in Table 3, all pathogenic fungi showed more than 95% inhibition rate, in particular, rot rot (rot), anthrax, spot deciduous (spot deciduous), ovule, stem blight (bronchial), blue Fungi, wilting disease, diarrhea, gray mold, root rot, purple-wing disease, and white-wing disease were all suppressed.

2) 길항성세균 CHO104 배양여액을 함유한 배지에서 식물 병원성 곰팡이 억제효과2) Inhibitory Effect of Plant Pathogenic Fungus on Media Containing Antagonistic Bacteria CHO104 Filtrate

길항성세균 CHO104 배양여액을 함유한 배지를 제조하였다. 즉, 250 mL의 물에 감자포도당 배지 39 g을 녹여 멸균한 후 충분히 식었을 때 750 mL의 CHO104 배양 여과액을 더하여 배지를 만들었다. 식물 병원성 곰팡이를 접종하여 30℃에서 7일간 배양하면서 곰팡이의 생육억제 정도를 조사하여 길항력 정도(Zone of Inhibition)로 나타내었다. 길항성세균 배양여액을 함유한 고체배지에서 식물 병원성 곰팡이를 배양한 결과 겹무늬썩음병(부패병), 탄저병, 점무늬낙엽병(반점낙엽병), 부란병, 줄기마름병(동고병), 시들음병, 뿌리썩음병, 자주날개무늬병(자문우병), 흰날개무늬병(흰문우병)의 곰팡이는 표 4에 제시한 바와 같이 완전히 생육이 억제되었다.A medium containing antagonistic bacteria CHO104 culture filtrate was prepared. That is, 39 g of potato glucose medium was dissolved in 250 mL of water and sterilized. After cooling, 750 mL of CHO104 culture filtrate was added thereto to prepare a medium. Inoculation of plant pathogenic fungi and incubation at 30 ° C. for 7 days was carried out to investigate the degree of growth inhibition of the fungus and expressed as the degree of antagonism (Zone of Inhibition). Phytopathogenic fungi were cultured in solid medium containing antagonistic bacterial culture filtrates; rotted rot, anthracnose, spotted deciduous disease, spot deciduous disease, ovule, stem blight, rot, rot, root rot The fungus of wing-pattern disease (marrow disease) and white-wing disease (white-moon disease) was completely inhibited as shown in Table 4.

3) 길항성세균 CHO104의 열처리배양액을 함유한 배지에서 식물 병원성 곰팡이 억제효과3) Inhibitory Effect of Plant Pathogenic Fungi on Medium Containing Heat Treatment Culture Solution of Antagonist Bacteria CHO104

길항성세균 열처리 배양액을 함유한 배지를 제조하였다. 즉, 배양후 원심분리하여 얻어진 상등액을 121℃에서 15분간 처리한 열처리배양액에 이 배양액 전체 부피에 해당하는 감자포도당 배지 39 g의 분말을 녹여 멸균한 후 배지를 만들었다. 식물 병원성 곰팡이를 접종하여 30℃에서 7일간 배양하면서 곰팡이의 생육억제 정도를 조사하여 길항력 정도(Zone of Inhibition)로 나타내었다. 길항성세균 열처리 배양액을 함유한 고체배지에서 식물 병원성 곰팡이를 배양한 결과, 겹무늬썩음병(부패병), 탄저병, 부란병, 줄기마름병(동고병), 시들음병, 잿빛곰팡이병, 뿌리썩음병, 자주날개무늬병(자문우병), 흰날개무늬병(흰문우병)등의 곰팡이 생육은 표 5에서 제시한 바와 같이 완전히 억제되었다.A medium containing antagonistic bacteria heat-treated culture was prepared. That is, after the culture supernatant obtained by centrifugation after culturing for 15 minutes at 121 ℃ dissolved in powder 39 g of potato glucose medium corresponding to the total volume of the culture medium in a heat treatment culture medium was prepared after sterilization. Inoculation of plant pathogenic fungi and incubation at 30 ° C. for 7 days was carried out to investigate the degree of growth inhibition of the fungus and expressed as the degree of antagonism (Zone of Inhibition). As a result of culturing plant pathogenic fungi in solid medium containing antagonistic bacterial heat-treatment broth, rot rot (rot), anthrax, ovulation, stem blight (warring disease), wilting disease, gray mold, root rot, purple wing pattern disease ( Fungal growth, such as advisory disease) and white-wing disease (white-moon disease) were completely suppressed as shown in Table 5.

(실시예 3) 길항성미생물 CHO104의 동정Example 3 Identification of Antagonistic Microorganism CHO104

길항력이 뛰어난 균주로 선발된 CHO104를 동정하기 위하여 미생물의 형태적 성질, 배양적 특성 및 생리 생화화적 성질 등을 검토하였다. 또한 BiologMicroLog34.01A로 동정한 결과 가능성(PROB) 99%, 유사성(SIM) 0.74의 결과로서Bacillus amyloliquefaciens로 동정되었다. 이러한 결과와 Bergey's manual of systematic bacteriology, microbiological method 등에 기술된 분류기준에 따라 CHO104 균주는 바실러스 아밀로리퀴파시엔스(Bacillus amyloliquefaciens)로 동정되었다. 이 길항미생물(Bacillus amyloliquefaciensCHO104)은 생명공학연구소에 수탁되었다.(수탁번호: KCTC 18060P).In order to identify CHO104, which was selected as an antagonistic strain, the morphological properties, culture characteristics, and physiological biochemical properties of microorganisms were examined. Biolog MicroLog 34.01A was identified as Bacillus amyloliquefaciens as a result of 99% likelihood (PROB) and similarity (SIM) 0.74. According to these results and the classification criteria described in Bergey's manual of systematic bacteriology and microbiological methods, the CHO104 strain was identified as Bacillus amyloliquefaciens . This antagonist ( Bacillus amyloliquefaciens CHO104) was entrusted to the Institute of Biotechnology (Accession No .: KCTC 18060P).

(실시예 4) 길항성세균Bacillus amyloliquefaciensCHO104(수탁번호: KCTC 18060P)의 배양Example 4 Culture of Antagonist Bacteria Bacillus amyloliquefaciens CHO104 (Accession Number: KCTC 18060P)

1) 배양온도에 따른 성장1) Growth according to culture temperature

Bacillus amyloliquefaciensCHO104의 성장최적조건을 설정하기 위해서 배양액의 온도를 25∼45℃ 범위에서 생육도를 조사하였다. 실험결과 33℃에서 생장이 가장 좋은 결과를 보였다.The growth of Bacillus amyloliquefaciens CHO104 was investigated in the temperature range of 25 ~ 45 ℃. Experimental results showed the best growth at 33 ℃.

2) 성장에 미치는 pH의 영향2) Effect of pH on Growth

배지의 pH를 변화시키면서 길항균을 배양한 결과 가장 적합한 pH의 범위는 7내외인 것으로 측정되었다.As a result of culturing the antagonists while changing the pH of the medium, the most suitable pH range was determined to be about 7.

3) 대량배양3) Bulk Cultivation

Bacillus amyloliquefaciensCHO104를 영양한천(Nutrient Agar)배지에서 2∼3회 정도 계대배양하여 활성화시킨 균주를 모균으로 하여, 1 백금이 정도의 균주를 5 mL의 SDBP (Soy Dextrose Beef ex. Proteos Peptone)배지(간장 3%, 포도당 5%, 비프 익스트렉트 0.1%, 프로테오스 펩톤 0.1%)에서 33℃, 12시간동안 배양하였다. SDBP배지에 넣고 배양한 후 배양한 균주 중에서 1%의 균주를 채취하여 새로운 SDBP배지에 옮겨 24시간 진탕 배양하여 길항원인물질의 규명에 사용하였다. Bacillus amyloliquefaciens CHO104 subcultured in a Nutrient Agar medium for 2 to 3 times as a parent strain, and 1 platinum strain was added to 5 mL of SDBP (Soy Dextrose Beef ex Proteos Peptone) medium ( Soy sauce 3%, glucose 5%, beef extract 0.1%, proteose peptone 0.1%) was incubated for 33 hours at 33 ℃. After incubation in SDBP medium, 1% of the strains were collected from the cultured strains, transferred to a new SDBP medium, and cultured for 24 hours to be used for identification of antagonists.

(실시예 5) 천연항균활성물질의 분리Example 5 Isolation of Natural Antibacterial Active Material

바실러스 아밀로리퀴파시엔스 CHO104의 배양액을 원심분리(5,000 rpm, 15 분)하여 균체를 제거한 배양여액(7 L)을 1 N HCl로 pH 3으로 조정한 다음, 에칠아세테이트로 분배하여 에칠아세테이트 가용 산성·중성획분(EtOAc-soluble acidic·neutral fraction)과 수상획분을 얻었다. 에칠아세테이트 가용 산성·중성획분을 pH 8.0으로 조정된 2% NaHCO3으로 분배하여, 에칠아세테이트 가용 중성획분(EtOAc-soluble neutral fraction)과 수상획분을 얻었다. 얻어진 각 획분의 항균활성을 페이퍼 디스크법(Zaika, L.L.,J. Food safety, 9, p. 97-118, 1988)으로 스타필로코코스 아우레우스(Staphylococcus aureus)와 곰팡이로서 보트리티스 시너레아(Botrytis cinerea)를 대상으로 검정한 결과, 에칠아세테이트 가용 중성 획분에서 강한 항균활성이 나타났으며, 이후 활성물질의 정제과정에서 항균활성검정은 스타필로코코스 아우레우스에 의한 활성여부로 수행하였다.The culture filtrate of Bacillus amyloliquifaciens CHO104 was centrifuged (5,000 rpm, 15 minutes), and the culture filtrate (7 L) from which the cells were removed was adjusted to pH 3 with 1 N HCl, and then partitioned with ethyl acetate. Neutral fraction (EtOAc-soluble acidic and neutral fraction) and aqueous fraction were obtained. The ethyl acetate soluble acidic and neutral fractions were partitioned with 2% NaHCO 3 adjusted to pH 8.0 to obtain an ethyl acetate soluble neutral fraction and an aqueous phase fraction. The antimicrobial activity of the obtained fractions was analyzed by Staphylococcus aureus and mold by the paper disk method (Zaika, LL, J. Food safety , 9, p. 97-118, 1988). Botrytis cinerea) showed strong antimicrobial activity in the ethyl acetate soluble neutral fraction, and the antimicrobial activity assay was then performed by Staphylococcus aureus to purify the active material.

에칠아세테이트 가용 중성획분(421 mg)을 실리카겔 흡착 컬럼 크로마토그래피를 이용하여 에칠아세테이트 용액에서 메탄올 용액의 농도를 점진적으로 높여 용출분획하여 활성을 검정한 결과, 활성은 에칠아세테이트-메탄올(100:0, v/v)획분에서 나타났으며, 활성 획분 127 mg을 얻었다. 이 활성분획물을 세파덱스 LH-20 컬럼 크로마토그래피(메탄올-클로로포름 4:1, v/v)로 분획하여 활성을 검정한 결과,Ve/Vt (elution volume/column bed volume) 0.64∼0.78의 위치에서 용출된 분획물에 활성이 나타났다. 이 활성획분(120 mg)을 옥타데실실란 컬럼 크로마토그래피( 메탄올-물)에 의해서 용출 분획하여 활성을 검정한 결과, 메탄올-물 80:20 (v/v)의 용매로 용출된 획분(14.6 mg)에 활성이 나타났다. 이 활성획분(14.6 mg)을 역상컬럼을 탑재한 HPLC (Senshu pak, 8 ×250 mm, 70% 메탄올, 1.5 mL/min)에 의하여 retention time 19분에 단일피크로 분리되어, 백색분말 형태로 3.36 mg을 성공적으로 단리하였다. 단리된 활성물질 10 ㎍을 6 mm paper disc에 올려 스트렙토코코스 아우레우스에 대한 활성을 검정한 결과, 생육억제환의 크기는 12 mm로, 대조구로 사용한 벤조산(200 ㎍)은 10 mm로 나타났다. 또한 단리된 활성본체의 최소저해농도(MIC)는 5 ㎍ 이하 수준이었다.Elution fractions of ethyl acetate soluble neutral fraction (421 mg) were gradually eluted by increasing the concentration of methanol solution in the ethyl acetate solution using silica gel adsorption column chromatography. v / v) fraction, yielding 127 mg of active fraction. This active fraction was fractionated by Sephadex LH-20 column chromatography (methanol-chloroform 4: 1, v / v) and assayed for activity.Ve/Vt (elution volume / column bed volume) was found at 0.64-0.78. Activity was shown in the eluted fractions. This active fraction (120 mg) was eluted with octadecsilane column chromatography (methanol-water) to assay for activity. As a result, a fraction eluted with a solvent of methanol-water 80:20 (v / v) (14.6 mg) was extracted. ) Showed activity. This active fraction (14.6 mg) was separated into single peaks at a retention time of 19 minutes by HPLC (Senshu pak, 8 × 250 mm, 70% methanol, 1.5 mL / min) equipped with a reversed phase column, and was formed into a white powder of 3.36. mg was successfully isolated. As a result of assaying the activity against Streptococcus aureus by placing 10 μg of the isolated active substance on a 6 mm paper disc, the size of the growth inhibitory ring was 12 mm, and benzoic acid (200 μg) used as a control was 10 mm. In addition, the minimum inhibitory concentration (MIC) of the isolated active body was 5 μg or less.

(실시예 6) 기기분석에 의한 아밀로리퀴톤의 구조결정Example 6 Structure Determination of Amyloquiquitone by Instrumental Analysis

아밀로리퀴톤의 구조를 결정하기 위하여 질량분석기(MS, Jeol JNM AX 505 WA, 30 eV)에 의해 측정된 질량 분석치는 통상의 EI-MS에서 채용하는 70 eV에서는 분자 개열이 심하여 분자 이온의 관측이 불가능하였으나, 30 eV로 낮추어 측정한 결과, 분자이온 [M+] 이m/z(rel. int.) 402(1.3)에서, 개열(fragment) 이온이 384(15.4), 366(18.6), 273(15.6), 255(16.0), 227(9.0), 172(20.7), 133(35.1), 107(54.8), 81(82.0), 67(base peak)에서 측정되었고, 고분해 질량분석(HR-MS)에 의해 분석된 값은m/z402.2401이었으며, 측정된 분자식은 C24H34O5이었다. 또한, 핵자기공명분석기(NMR, Varian Unity Inova 500, 500 MHz, CD3OD)에 의해 측정된1H-NMR,13C-NMR, HMBC(하기에 스펙트럼제시)등의 분석 결과와 질량분석의 결과를 종합하여 아밀로리퀴톤의 구조를 하기와 같이 결정하였다.The mass spectrometry measured by mass spectrometer (MS, Jeol JNM AX 505 WA, 30 eV) to determine the structure of amyloriquitone was severe molecular cleavage at 70 eV employed in conventional EI-MS. Although not possible, the molecular ion [M +] was measured in m / z ( rel. Int. ) At 402 (1.3), and the fragment ions were 384 (15.4), 366 (18.6), 273 ( 15.6), 255 (16.0), 227 (9.0), 172 (20.7), 133 (35.1), 107 (54.8), 81 (82.0), 67 (base peak), and high resolution mass spectrometry (HR-MS). ) Was m / z 402.2401, and the measured molecular formula was C 24 H 34 O 5 . In addition, the results of analysis and mass spectrometry such as 1 H-NMR, 13 C-NMR, and HMBC (spectral presentation) measured by a nuclear magnetic resonance analyzer (NMR, Varian Unity Inova 500, 500 MHz, CD 3 OD) Based on the results, the structure of amyloriquitone was determined as follows.

(실시예 7) 아밀로리퀴톤의 항균활성 검정Example 7 Antibacterial Activity Assay of Amyloquiquitone

실시예 5에서 기술한 방법으로 바실러스 아밀로리퀴파시엔스 CHO104의 배양액으로부터 단리된 아밀로리퀴톤의 항균활성을 페이퍼 디스크법(Zaika, L.L.,J.Food safety, 9, p. 97-118, 1988)으로 실시하였다. 즉, 푸어 플레이트 방법(pour plate method)에 의해 45℃로 조절된 멸균배지 20 mL에 스타필로코코스 아우레우스(Staphylococcus aureusKCTC1928)의 전배양액 0.1 mL를 혼합시킨 후, 페트리디쉬에 넣고 응고시킨 다음, 항균 활성물질이 포함된 6 mm 크기의 페이퍼디스크를 올려 0.85% 식염수로 확산시킨 후 30℃에서 16시간 배양하여 생육저해환의 크기(mm)로 효과를 측정하였다. 배지는 뉴트리언트(Nutrient) 배지(Difco)를 사용하였다. 또한 곰팡이에 대한 항진균활성검정은 보트리티스 시너레아(Botrytis cinerea)의 포자를 도말한 감자포도당 한천배지(PDA Plate, 두께 4 mm)상에 생육저해(Inhibition zone)를 형성하는 방법으로 검정하였다. 즉, 멸균된 cork borer(직경 9 mm)를 사용하여, 원형의 agar hole를 만든 후 아밀로리퀴톤을 넣어 28℃에서 4일간 배양시킨 후 그 생육저해의 크기로 활성을 측정하였다. 스타필로코코스 아우레우스와 보트리티스 시너레아를 대상으로 벤조산(benzoic acid)를 대조구로 하여측정된 결과는 표 6과 같다.The antimicrobial activity of amyloriquitone isolated from the culture solution of Bacillus amyloliquifaciens CHO104 by the method described in Example 5 was determined by the paper disk method (Zaika, LL, J. Food safety , 9, p. 97-118, 1988). Was carried out. That is, 0.1 mL of the preculture solution of Staphylococcus aureus KCTC1928 was mixed with 20 mL of sterile medium adjusted to 45 ° C. by the pour plate method, and then solidified in a Petri dish. , 6 mm paper disk containing the antimicrobial active material was put up and diffused with 0.85% saline, and then cultured at 30 ° C. for 16 hours to measure the effect of growth inhibition ring size (mm). Nutrient medium (Difco) was used as the medium. In addition, the antifungal activity test against the fungus was assayed by forming an inhibition zone on potato glucose agar plates (4 mm thick) coated with spores of Botrytis cinerea . In other words, using a sterilized cork borer (diameter 9 mm), after making a round agar hole and put amyloriquitone incubated at 28 ℃ for 4 days, the activity was measured by the size of the growth inhibition. Table 6 shows the results measured using benzoic acid as a control in Staphylococcus aureus and Botrytis sinerea.

즉, 아밀로리퀴톤은 곰팡이 및 세균에 대해 강한 항균활성을 나타내었다.That is, amyloriquitone showed strong antimicrobial activity against fungi and bacteria.

본 발명은 토양에서 길항성 미생물로 선발되어, 바실러스 아밀로리퀴파시엔스로 동정된 바실러스 아밀로리퀴파시엔스 CHO104(수탁번호: KCTC 18060P) 및 이 미생물의 배양액에서 항균활성물질로 분리되고 구조 결정된 아밀로리퀴톤과 이 미생물을 포함한 배양액은 천연 항균제로써 의약품, 농약, 식품 등에 광범위하게 이용 될 수 있다.The present invention has been selected as antagonistic microorganisms in soil, identified as Bacillus amyloliquifaciens Bacillus amyloliquifaciens CHO104 (Accession Number: KCTC 18060P) and structured amyloid separated from the culture medium of this microorganism as an antimicrobial active material Loriquiton and the culture medium containing this microorganism are natural antimicrobials and can be widely used in medicines, pesticides, and foods.

Claims (8)

토양에서 분리된 길항성 미생물 바실러스 아밀로리퀴파시엔스 CHO104 (Bacillus amyloliquefaciensCHO 104, 수탁번호: KCTC 18060P) 및 이 미생물 배양액으로 구성된 미생물제제.An antagonistic microorganism Bacillus amyloliquefaciens CHO 104 (Accession No .: KCTC 18060P) isolated from soil and a microbial agent consisting of this microbial culture. 제 1항에 있어서, 미생물 제제에 적용할 수 있는 식물의 병원균은 겹무늬썩음병(부패병), 탄저병, 점무늬낙엽병(반점낙엽병), 부란병, 줄기마름병(동고병), 참다래과실무름병, 시들음병, 잘록병(입고병), 잿빛곰팡이병, 뿌리썩음병, 자주날개무늬병(자문우병), 흰날개무늬병(흰문우병)의 병원성 곰팡이를 포함한 식물 병원균을 특징으로 하는 미생물제제.The pathogen of the plant which can be applied to the microbial preparation is a rot, anthrax, spotted deciduous disease, spot deciduous disease, stem blight, rhythm blight, wilted fruit disease, wilt disease Microorganisms characterized by plant pathogens, including pathogenic fungi, such as (disease disease), gray mold disease, root rot disease, purple-winged disease, and white-winged disease. 제 1항에 있어서, 상기 균주를 SDBP(Soy Dextrose Beef ex. Proteos Peptone)배지(간장 3%, 포도당 5%, 비프 익스트렉트 0.1%, 프로테오스 펩톤 0.1%)에서 30∼35℃에서 배양시킴을 특징으로 하는 미생물제제.The method of claim 1, wherein the strain is incubated at 30 to 35 ℃ in Soy Dextrose Beef ex Proteos Peptone medium (soy 3%, glucose 5%, beef extract 0.1%, proteose peptone 0.1%) Microbial agent characterized in that. 바실러스 아밀로리퀴파시엔스 CHO104(수탁번호: KCTC 18060P)의 배양액으로부터 분리하여 얻은 항균활성물질인 아밀로리퀘톤(Amyloliquetone).Amyloliquetone, an antimicrobial active material obtained from a culture of Bacillus amyloliquifaciens CHO104 (Accession No .: KCTC 18060P). 바실러스 아밀로리퀴파시엔스 CHO104의 배양단계와 배양여액 분리단계, 그리고 상기 배양액을 pH 3(1 N HCl)으로 조절하여 분배한 수상획분과 에칠아세테이트 가용 산성·중성획분(EtOAc-soluble acidic·neutral fraction)분리단계와, 상기의 에칠아세테이트 가용 산성·중성획분을 다시 약알칼리성인 2∼5%의 NaHCO3(pH 8.0)용액과 분배한 후 수상획분과 에칠아세테이트 가용 중성획분으로 분리하는 단계와, 상기의 에칠아세테이트 중성획분을 실리카겔 흡착 컬럼 크로마토그래피에 의해서 에칠아세테이트에 메탄올의 농도를 점진적으로 높여 용출분획하여 활성획분을 얻는 단계와, 상기의 획분을 세파덱스 LH-20 컬럼 크로마토그래피에 의하여 활성획분을 분리하는 겔 여과 단계와, 상기의 활성획분을 옥타데실실란 컬럼 크로마토그래피로 활성획분을 분리하는 단계와, 상기의 정제된 활성획분을 역상의 HPLC로 메탄올-물의 용매계에 의하여 단리하는 단계를 포함하는 것을 특징으로 하는 바실러스 아밀로리퀴파시엔스 CHO104가 생산하는 항균활성물질의 제조방법.Culture step of Bacillus amyloliquifaciens CHO104, separation of the culture filtrate, and the aqueous phase fraction and the ethyl acetate soluble acidic and neutral fraction (EtOAc-soluble acidic / neutral fraction) distributed by adjusting the culture medium to pH 3 (1 N HCl) Separation step and the step of diluting the above ethyl acetate soluble acidic and neutral fractions with a weak alkaline 2-5% NaHCO 3 (pH 8.0) solution and separating the aqueous fractions and the ethyl acetate soluble neutral fractions, and Elution fractions of the ethyl acetate neutral fractions were gradually eluted by increasing the concentration of methanol in the ethyl acetate by silica gel adsorption column chromatography to obtain the active fractions, and the active fractions were separated by Sephadex LH-20 column chromatography. A gel filtration step for separating and separating the active fraction from the active fraction by octadecyl column chromatography; The method of antibacterial material disclosed is Bacillus amyl quinone Lowry Pacific Enschede CHO104 characterized in that it comprises the step of isolating the water-based solvent by the production - with the group of the purified active fractions of the reverse phase HPLC of methanol. 제 4항의 활성물질인 아밀로리퀴톤을 포함한 바실러스 아밀로리퀴파시엔스 CHO104 배양약을 의약품, 농약, 식품 등의 미생물제제로 이용하는 방법.A method of using Bacillus amyloliquifaciens CHO104 culture drug containing amyloliquitone, the active substance of claim 4, as a microbial agent for medicines, pesticides, and foods. 제 4항의 항균활성물질인 아밀로리퀴톤을 다양한 활성물질의 선도물질 또는 의약품, 농약, 식품 등에 이용하는 방법.A method of using the amyloriquitone, the antimicrobial active substance of claim 4, as a leading substance of various active substances or medicines, pesticides, foods, etc. 제 4항의 아밀로리퀴톤의 구조에 다른 다양한 관능기를 붙이거나 치환하여이용하는 방법.A method of attaching or substituting other functional groups to the structure of amyloriquitone according to claim 4 for use.
KR10-2000-0081428A 2000-12-23 2000-12-23 Bacillus Amyloliquefaciens CHO104 with Antagonic Property and Antimicrobial Compound Produced by This Strain Expired - Fee Related KR100423121B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2000-0081428A KR100423121B1 (en) 2000-12-23 2000-12-23 Bacillus Amyloliquefaciens CHO104 with Antagonic Property and Antimicrobial Compound Produced by This Strain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0081428A KR100423121B1 (en) 2000-12-23 2000-12-23 Bacillus Amyloliquefaciens CHO104 with Antagonic Property and Antimicrobial Compound Produced by This Strain

Publications (2)

Publication Number Publication Date
KR20020051803A true KR20020051803A (en) 2002-06-29
KR100423121B1 KR100423121B1 (en) 2004-03-18

Family

ID=27685526

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2000-0081428A Expired - Fee Related KR100423121B1 (en) 2000-12-23 2000-12-23 Bacillus Amyloliquefaciens CHO104 with Antagonic Property and Antimicrobial Compound Produced by This Strain

Country Status (1)

Country Link
KR (1) KR100423121B1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426930B1 (en) * 2001-06-29 2004-04-13 한국생명공학연구원 Novel Bacillus amyloliquefaciens B4 strain producing fermented swine feed utilizing food waste
KR100429586B1 (en) * 2001-08-09 2004-05-04 주식회사 한국메디 Novel Bacillus Amyloliquefaciens KM112 Strain and Antifungial Composition Using the Same
KR100472376B1 (en) * 2002-05-24 2005-03-08 주식회사 백광소재 Bacillus amyloliquefaciens LX 9 and method for culturing thereof
KR100807403B1 (en) * 2006-07-26 2008-02-28 동아대학교 산학협력단 Bacillus amylolytic spp.03 strain for controlling plant ash mold fungus and preparation method of microorganism using the same
KR100868901B1 (en) * 2007-04-25 2008-11-14 동아대학교 산학협력단 Bacillus amyloliquefaciens strains and preparations containing the same
KR100919892B1 (en) * 2007-12-27 2009-10-01 조선대학교산학협력단 Bacillus subtilis separated from meju and a antimicrobial composition comprising the same
WO2014129680A1 (en) * 2013-02-21 2014-08-28 (주)한국바이오케미칼 Technique, method, and composition for controlling plant pathogens
US9080219B2 (en) 2007-03-13 2015-07-14 Korea Research Institute Of Bioscience And Biotechnology Bacillus amyloliquefaciens K317 for suppressing the growth of antibiotics-resistant pathogenic microorganism or enteropathogenic microorganism
CN115490753A (en) * 2022-06-27 2022-12-20 宁波大学 A kind of cyclic lipopeptide compound and its preparation method and application
KR20230100369A (en) * 2021-12-28 2023-07-05 강원특별자치도 New Bacillus amyloliquefaciens strain and uses thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101066877B1 (en) 2008-09-11 2011-09-26 목포대학교산학협력단 Fermentation Compost for Biological Control of Thymus Disease through Intellectual Enhancement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3560653B2 (en) * 1993-09-30 2004-09-02 ヒゲタ醤油株式会社 Method for producing iturin A and anti-deep mycosis agent
JPH11163A (en) * 1997-06-13 1999-01-06 Asada Shoji Kk Thermostable antibiotic-producing thermoresistant bacillus, lawn grass disease inhibitor and plant activator having its product as effective component
KR100325634B1 (en) * 1998-12-30 2004-12-23 동부한농화학 주식회사 Microorganisms with antifungal activity against pathogenic fungi, antifungal microbial pesticides containing them and methods for their preparation
KR100319135B1 (en) * 1999-08-23 2001-12-29 조정일 Microbiological preparation inhibiting plant diseases
KR100380535B1 (en) * 2000-04-25 2003-04-16 조정일 Control of aflatoxin using inhibition microorganism CP220 and bean fermentation food and animal feed applied to such microorganism

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426930B1 (en) * 2001-06-29 2004-04-13 한국생명공학연구원 Novel Bacillus amyloliquefaciens B4 strain producing fermented swine feed utilizing food waste
KR100429586B1 (en) * 2001-08-09 2004-05-04 주식회사 한국메디 Novel Bacillus Amyloliquefaciens KM112 Strain and Antifungial Composition Using the Same
KR100472376B1 (en) * 2002-05-24 2005-03-08 주식회사 백광소재 Bacillus amyloliquefaciens LX 9 and method for culturing thereof
KR100807403B1 (en) * 2006-07-26 2008-02-28 동아대학교 산학협력단 Bacillus amylolytic spp.03 strain for controlling plant ash mold fungus and preparation method of microorganism using the same
US9080219B2 (en) 2007-03-13 2015-07-14 Korea Research Institute Of Bioscience And Biotechnology Bacillus amyloliquefaciens K317 for suppressing the growth of antibiotics-resistant pathogenic microorganism or enteropathogenic microorganism
KR100868901B1 (en) * 2007-04-25 2008-11-14 동아대학교 산학협력단 Bacillus amyloliquefaciens strains and preparations containing the same
KR100919892B1 (en) * 2007-12-27 2009-10-01 조선대학교산학협력단 Bacillus subtilis separated from meju and a antimicrobial composition comprising the same
WO2014129680A1 (en) * 2013-02-21 2014-08-28 (주)한국바이오케미칼 Technique, method, and composition for controlling plant pathogens
KR101447019B1 (en) * 2013-02-21 2014-10-07 (주)한국바이오케미칼 Composition, method and application for anti plant pathogen
KR20230100369A (en) * 2021-12-28 2023-07-05 강원특별자치도 New Bacillus amyloliquefaciens strain and uses thereof
CN115490753A (en) * 2022-06-27 2022-12-20 宁波大学 A kind of cyclic lipopeptide compound and its preparation method and application

Also Published As

Publication number Publication date
KR100423121B1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
Winkelmann Pyrrolnitrin from Burkholderia cepacia: antibiotic activity against fungi and novel activities against streptomycetes
Kneifel et al. Ophiocordin, an antifungal antibiotic of Cordyceps ophioglossoides
Tarus et al. Bioactive metabolites from Trichoderma harzianum and Trichoderma longibrachiatum
KR100423121B1 (en) Bacillus Amyloliquefaciens CHO104 with Antagonic Property and Antimicrobial Compound Produced by This Strain
Pore et al. Production, purification, identification of prodigiosin from Serratia sp. and its antimicrobial activity
GB2220657A (en) Antifungal fermentation product
KR20070077357A (en) Novel Bacillus atropes CNU05-1 and composition for controlling plant bottles using the same
Zhang et al. Antimicrobial activity of endophytic fungus Fusarium sp. isolated from medicinal honeysuckle plant
AU659610B2 (en) Cold tolerant trichoderma
KR100523264B1 (en) Novel streptomyces sp. producing antibacterial and antifungal agent
Rante et al. Antimicrobial activity of Streptomyces spp. sponge-associated isolated from Samalona Island of South Sulawesi, Indonesia
Veilumuthu et al. Antimicrobial compounds produced by Streptomyces sp. VITGV01 against selected human pathogens
WO2010115802A1 (en) New actinomycetes strain compositions and their use for the prevention and/or the control of micro organism inducing plant diseases
Pervez et al. In vitro antimicrobial studies of isolated Myrothecium spp mrp001 against human pathogens
Choi et al. Broad-spectrum In vitro antimicrobial activities of Streptomyces sp. strain BCNU 1001
KR100477890B1 (en) A new Streptomyces sp. 8E12 and its use as a herbicidal agent
Wang et al. Manumycin-type derivatives from a Streptomyces sp. associated with meson bee Osmia cornifrons
Muhsin et al. Preliminary screening of bioactive metabolites from three fungal species of Drechslera isolated from soil in Basrah, Iraq
KR102129427B1 (en) Novel microorganism Brevibacillus sp. TGS2-1 and compounds isolated from TGS2-1 strain for inhibiting growth of methicillin resistance Staphylococcus aureus
Yulianis et al. Ethyl acetate extracts endophytic fungi from the medicinal tree fern cyathea contaminans (Hook) copel with antimicrobial activity
KR20050119800A (en) Xylaria sp. ah001 strain producing griseofulvin, formulation for controlling plant diseases containing same and method for controlling plant diseases using same
KR100327510B1 (en) Antifungal activity and Preparation-method of antibiotics produced from Micromonospora coerulea Ao58
RU2817695C1 (en) Streptomyces species yvz014 strain - producer of antibiotic lysolipine x
KR100489914B1 (en) Preparation method and antioomycete activity of a novel antibiotic produced by Lechevalieria aerocolonigenes strain VK-A9 against Phytophthora capsici
KR20190053475A (en) A composition for rice bacterial blight suppressing activity

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20001223

PA0201 Request for examination
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20020125

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20030701

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20040205

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20040304

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20040304

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20070307

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20080111

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20090304

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20100308

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20110225

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20110225

Start annual number: 8

End annual number: 8

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

Termination category: Default of registration fee

Termination date: 20130209